Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | AZD0516 |
| Trade Name | |
| Synonyms | AZD-0516|AZD 0516 |
| Drug Descriptions |
AZD0516 is an antibody-drug conjugate (ADC) comprising an antibody targeting STEAP2 linked to exatecan, which potentially induces cytotoxicity against STEAP2-expressing tumor cells and inhibits tumor growth (Cancer Res (2025) 85 (8_Supplement_1): 1158). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| AZD0516 | AZD0516 | 0 | 1 |
| AZD0516 + AZD9574 | AZD0516 AZD9574 | 0 | 1 |